Bioventix PLC

1,950pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:BVXPHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR 8.44%
Div yield 7.69%
ROE 66.31%
Biotechnology
Beta (5Y) 0.51
PE TTM 13.58
TSR TTM 6.76%
Mkt cap £101.9M
ROIC 121.27%
SE Grade™
Value
Quality
Moat
Consensus
Reference
1,881p
(3.51%)
(93.59%)
Hold 8|2|2|11|3
2Q26
3Q26
4Q26
1Q27
Earnings per share£
23.65
24.38
26.66
26.46
4.10%
11.06%
18.41%
22.23%
Revenue£M
6.098
6.263
6.378
6.601
14.55%
13.99%
10.70%
12.96%
Peers (US$137.1M)
Cap (US$)
PE
110.0M
—
Capital
TTM
5Y
10Y
Leveragex
0.137
0.027
0.027
EBIT/Intx
0.638
0.376
0.355
Own earn%
29.35
12.34
9.64
Sh yield%
9.70
28.62
29.62
Owners
Insiders/Inst%
0.30
22.66
Short interest%
5.35
SBC / revenue%
3.30
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
3–8
$1 testx
—
Incr. ROIC%
17